ARS PHARMACEUTICALS INC (SPRY) Institutional Ownership and Insiders Activity
ARS PHARMACEUTICALS INC (SPRY) is widely held by institutional investors, with 201 firms reporting positions valued at approximately $709.94M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Ra Capital Management, L.P. is the largest disclosed holder, reporting approximately $87.00M in SPRY holdings in its latest filing.
Institutional Holders
201
Total Reported Value
$709.94M
Largest Holder
Ra Capital Management, L.P.
Largest Position
$87.00M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
185
Funds Exiting Positions
1
Top Institutional Owners
View allInvestorReported Balance
- Ra Capital Management, L.P.$87.00M
- Rubric Capital Management Lp$68.41M
- Orbimed Advisors Llc$66.39M
- Deerfield Management Company, L.P.$60.11M
- Blackrock, Inc.$42.54M
Related SPRY Institutional Insights:
- SPRY 13F Institutional Holders
- SPRY Superinvestors
- SPRY Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- SPRY Insider Trading & SEC Form 4 Activity
- SPRY Articles
- Top Institutional Investor Stock Rankings